Intralytix and Life Extension Collaborate to Advance Bacteriophage-Based Interventions in the VMS Space

October 6, 2025. Intralytix is excited to announce a new agreement with Life Extension to co-develop and commercialize a leading-edge phage-based nutraceutical aimed at
Dr. Alexander "Sandro" Sulakvelidze, President & CEO of Intralytix.expanding the role of bacteriophage technology within the vitamins, minerals, and supplements (VMS) sector.

“This collaboration represents an important step forward in bringing precision-targeted, natural health solutions to more people,” said Dr. Alexander “Sandro” Sulakvelidze, President and CEO of Intralytix. “By combining Intralytix’s leadership and pioneering expertise in bacteriophage science with Life Extension’s trusted reach in the health and wellness market, we are paving the way for a new generation of safe, effective phage-based products that can help support diverse health needs.”

The collaboration highlights a shared focus on pioneering microbiome-targeted interventions and personalized wellness strategies, with Intralytix bringing its cutting-edge bacteriophage expertise to the forefront. It also establishes a framework for the development of evidence-based, phage-powered nutraceutical formulations designed to promote gut microbiota balance, immune function, and overall human health.

About Intralytix, Inc.

Headquartered in Columbia, Maryland, Intralytix is the world’s leading developer of bacteriophage-based products for food safety, human health, veterinary applications, and environmental remediation. The company currently markets a range of FDA-cleared and USDA-approved phage products and maintains a robust pipeline of novel nutraceutical and therapeutic antimicrobial interventions targeting antibiotic-resistant and foodborne pathogens. For more information, please visit www.intralytix.com or contact:

Alexander Sulakvelidze
President & CEO
Intralytix, Inc.
asulakvelidze@intralytix.com
+1 (410) 625-2533